Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes
Journal
Diabetes
Journal Volume
60
Journal Issue
3
Pages
993
Date Issued
2011-03
Author(s)
Wei, Jung-Nan
Lin, Cheng-Hsin
Hua, Cyue-Huei
Smith, David J
Vanio, Jani
Abstract
Vascular adhesion protein-1 (VAP-1) participates in inflammation and catalyzes the breakdown of amines to produce aldehyde, hydrogen peroxide, and ammonia. Serum VAP-1 correlates positively with both acute hyperglycemia and diabetes. We conducted a cohort study to evaluate whether serum VAP-1 predicts 10-year survival in type 2 diabetic patients.
Subjects
SENSITIVE AMINE OXIDASE; COLORECTAL-CANCER; P-SELECTIN; INSULIN; BINDING; RISK; OVEREXPRESSION; ADIPOCYTES; VAP-1/SSAO; MELLITUS
SDGs
Publisher
AMER DIABETES ASSOC
Type
journal article